
CARB-X Funding Round (Drug-Resistant Bacteria R&D)
Opens 10 Nov 2026 CARB-X, led by Boston University United States
Amount set per project
- R&D funding for new antibacterials, and for neonatal sepsis prevention and diagnostics
- Drug, preventive or diagnostic developers worldwide
- Project must fit one of the four 2026 themes
- The company pays a share of the project cost
- Academic teams can apply if industry ready
- Opens 10 Nov 2026
- Submit an expression of interest on the CARB-X portal from 10 to 23 November
- Prototype stage
- International programmes
Similar grants
- Open all yearGrant

DIV Fund (successor to USAID Development Innovation Ventures)
DIV Fund (independent non-profit, ex USAID DIV team) - Open all yearGrant

UNICEF Venture Fund
UNICEF Venture Fund - Open all yearGrant

C-CAMP Wadhwani Innovation Network (WIN) Centre of Excellence
C-CAMP Bengaluru with Wadhwani Foundation - Closes 30 Nov 2026Grant

ICMR First in the World Challenge
Indian Council of Medical Research, Department of Health Research
Related grants
Starter opens 30 grants in full. Pro opens every one.